397 related articles for article (PubMed ID: 26152604)
1. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A
J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation.
Vlachos K; Efremidis M; Bazoukis G; Letsas KP; Saplaouras A; Georgopoulos S; Karamichalakis N; Rokiza A; Sakellaropoulou A; Kolokathis AM; Efremidis T; Asvestas D; Sideris A
Clin Cardiol; 2017 Oct; 40(10):847-852. PubMed ID: 28561951
[TBL] [Abstract][Full Text] [Related]
3. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.
Bassiouny M; Saliba W; Rickard J; Shao M; Sey A; Diab M; Martin DO; Hussein A; Khoury M; Abi-Saleh B; Alam S; Sengupta J; Borek PP; Baranowski B; Niebauer M; Callahan T; Varma N; Chung M; Tchou PJ; Kanj M; Dresing T; Lindsay BD; Wazni O
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):460-6. PubMed ID: 23553523
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation.
Aoyama D; Miyazaki S; Hasegawa K; Kaseno K; Ishikawa E; Mukai M; Miyahara K; Aiki T; Matsui A; Yamaguchi J; Shiomi Y; Tama N; Ikeda H; Fukuoka Y; Morishita T; Ishida K; Uzui H; Tada H
Int Heart J; 2019 Nov; 60(6):1315-1320. PubMed ID: 31735780
[TBL] [Abstract][Full Text] [Related]
5. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
[TBL] [Abstract][Full Text] [Related]
6. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
Kaiser DW; Streur MM; Nagarakanti R; Whalen SP; Ellis CR
J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
[TBL] [Abstract][Full Text] [Related]
7. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
[TBL] [Abstract][Full Text] [Related]
8. Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation.
Hansen PS; Sanchez R; Walfridsson H
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836793
[TBL] [Abstract][Full Text] [Related]
9. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
[TBL] [Abstract][Full Text] [Related]
10. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study.
Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP
J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959
[TBL] [Abstract][Full Text] [Related]
11. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
[TBL] [Abstract][Full Text] [Related]
12. Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment.
Zhang RF; Ma CM; Wang N; Yang MH; Li WW; Yin XM; Dong YX; Yu XH; Xiao XJ; Xia YL; Gao LJ
BMC Cardiovasc Disord; 2021 Apr; 21(1):214. PubMed ID: 33906609
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
Nin T; Sairaku A; Yoshida Y; Kamiya H; Tatematsu Y; Nanasato M; Inden Y; Hirayama H; Murohara T
Pacing Clin Electrophysiol; 2013 Feb; 36(2):172-9. PubMed ID: 23121681
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin.
Tao S; Otomo K; Ono Y; Osaka Y; Hirao T; Koura K; Manno T; Ueshima D; Shimizu S; Isobe M; Hirao K
J Interv Card Electrophysiol; 2017 Mar; 48(2):167-175. PubMed ID: 27943112
[TBL] [Abstract][Full Text] [Related]
16. Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.
Dillier R; Ammar S; Hessling G; Kaess B; Pavaci H; Buiatti A; Semmler V; Kathan S; Hofmann M; Lennerz C; Kolb C; Reents T; Deisenhofer I
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):576-82. PubMed ID: 24970293
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
Di Biase L; Lakkireddy D; Trivedi C; Deneke T; Martinek M; Mohanty S; Mohanty P; Prakash S; Bai R; Reddy M; Gianni C; Horton R; Bailey S; Sigmund E; Derndorfer M; Schade A; Mueller P; Szoelloes A; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Hongo RH; Beheiry S; Pürerfellner H; Burkhardt JD; Natale A
Heart Rhythm; 2015 Jun; 12(6):1162-8. PubMed ID: 25728754
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation.
Nakamura R; Okishige K; Shigeta T; Nishimura T; Kurabayashi M; Yamauchi Y; Sasano T; Hirao K
J Cardiol; 2019 Aug; 74(2):150-155. PubMed ID: 31029455
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
Providência R; Marijon E; Albenque JP; Combes S; Combes N; Jourda F; Hireche H; Morais J; Boveda S
Europace; 2014 Aug; 16(8):1137-44. PubMed ID: 24550347
[TBL] [Abstract][Full Text] [Related]
20. Catheter ablation of left atrial arrhythmias on uninterrupted oral anticoagulation with vitamin K antagonists: What is the relationship between international normalized ratio, activated clotting time, and procedure-related complications?
Kottmaier M; Bourier F; Semmler V; Telishevska M; Koch-Büttner K; Lennerz C; Lengauer S; Kornmayer M; Rousseva E; Brooks S; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I; Reents T
J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1415-1422. PubMed ID: 28800176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
